Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

11. November 2025 09:00 ET | Quelle: Precedence Research

U.S. Clinical Trial Imaging Market to Worth USD 1,675.4 Million by 2034, Growing at 9.37% CAGR

Ottawa, Nov. 11, 2025 (GLOBE NEWSWIRE) -- The U.S. clinical trial imaging market size was valued at USD 684 million in 2024 and is predicted to hit around USD 1675.4 million by 2034, rising at a...
30. Oktober 2025 11:00 ET | Quelle: Precedence Research

Clinical Trial Imaging Market to Reach USD 5.58 Billion by 2034, Driven by Growing Adoption of Advanced Imaging Technologies

Ottawa, Oct. 30, 2025 (GLOBE NEWSWIRE) -- The global clinical trial imaging market size was valued at USD 2.41 billion in 2024 and is predicted to hit around USD 5.58 billion by 2034,...
13. Oktober 2025 08:00 ET | Quelle: Precedence Research

Clinical Trial Design Market Size to Gain USD 1,228.57 Million by 2034

Ottawa, Oct. 13, 2025 (GLOBE NEWSWIRE) -- The global clinical trial design market size was valued at USD 567.66 million in 2024 and is predicted to hit around USD 1,228.57 million by 2034, rising at...
26. November 2018 08:00 ET | Quelle: ITL Pharma, Inc.

ITL Pharma Receives United States Patent Protection for Carcinin® Using Halogenated Phenol Ethers for Diagnostics, Antioxidant Protection and Drug Delivery

KINGSPORT, Tenn., Nov. 26, 2018 (GLOBE NEWSWIRE) -- ITL Pharma, Inc. (ITL), a LIAS Company, today announced awarding of a United States Patent allowance (S.N. 15/336,179) titled: "Halogenated...